Search Results
Results found for "Gregory Tall"
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
We’re not talking about personality clashes or investor drama. 👉 We’re talking about the type of quiet That’s what we call the hidden burn . 👉 This post breaks down how biotech misalignment happens, what ’s wrong, but no one’s aligned. 2️⃣ Founder-team decision asymmetry 👉 The founders make strategic calls It does not go away with more meetings, louder all-hands sessions, or rewritten pitch decks. 👉 It only decisions are made and what truly matters inside your company. 1️⃣ The first shift is reframing what you call
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Terry Kenakin to elevate your science and sharpen your calls. But kinetics tells the truth. signals today will shape tomorrow’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Everything you need to master GPCR science — in one membership. 🎓 Full GPCR University + 🔬 200+ expert talks
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
This week, we focus on how to convert ambiguous data into confident, defensible Mechanism of Action calls—before druggability 🔹 The role of cryo-EM in capturing fully activated GPCR complexes 📅 Catch Aaron’s full talk signals today will shape tomorrow’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
the receptors the effects are different depending on which signaling pathway is activated, which is called The data obtained is comparable to those reported in radioligand binding assays (Table 1). Δ9-THC, Δ9-THCA and Δ9-THCV.Data represent the mean ± SEM (n = 5 in triplicates) Table
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Table 1. Table 2. molecules tested, and their pKi values compared to literature data in Table 2 . Table 3. M.; Roux, T.; Cottet, M.; Durroux, T.; Douzon, S.; Bdioui, S.; Gregor, N.; Bourrier, E.; Oueslati, N.
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
protein coupled receptor signaling in its physiological cellular context” symposium and our featured talk Solve the problem of information overload by getting a curated summary of the key talks and discussions Avoid the professional threat of falling behind your peers by accessing the same insights that are driving lessons, classified industry news, priority event alerts, job opportunities, and insider commentary—all Don’t Fall Behind—Access the Edge You Need 👉 Become a Premium Member Today ➤ Already a Premium Member
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Thank you to all participants in Dr. Terry Kenakin's educational initiative this fall! GPCR News Let’s dive into the Classified GPCR News from October 21st to 27th, 2024 Industry News Call
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
The call from David — the glowing islet — created a pivot the team couldn’t ignore. The Human Reaction Behind a GPCR Imaging Milestone Scientists rarely talk about the emotional side of Two-photon microscopy revealed a glowing islet in a living mouse — a moment JB calls the “Holy Grail”
- Curve Shifts Don’t Lie, But Your Eyes Might
You need statistical methods that tell you, with confidence, whether the effect you’re seeing is real What you need is a number that tells you whether those differences are real. When Curves Shift Some of the most difficult calls in pharmacology happen when two curves look slightly Straight Lines, Slopes, and Systems Not all data bends into curves. , you’re leaving risk on the table.
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
Interface from Molecular Dynamics Simulations and Quantum Chemical Calculations "Allosteric modulators are called raises many questions about the ligand interactions and stability, the binding site structure, and how all Although ligand-lipid interactions are weak, lipid tails play a role in ligand binding pose stability
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Why Speed Matters in GPCR Drug Discovery Nine out of ten GPCR programs stall not because the target Programs stall. Timelines stretch. GPCR Kinetics: The Critical Data You Can’t Afford to Skip Equilibrium potency data only tells part of Key Questions Answered in this AMA Session How early in vivo models sharpen go/no-go calls. Every molecule tells a story about how it binds, signals, and behaves.
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
decision you make shapes your entire pipeline trajectory—and understanding when equilibrium affinity falls All curated for speed, relevance, and immediate application—only for Premium Members. Terry Kenakin’s featured talk on “The Kinetics of Allostery” offers a rare live glimpse into advanced Don’t Fall Behind—Access the Edge You Need 👉 Ready to sharpen your discovery decisions? Access this week’s full Premium Edition here ➤ Access all the news and upcoming events Hashtags: #
- From Pipettes to Platforms: The Evolution of GPCR Research
It’s a call to see your lab bench not as a constraint, but as a launchpad. 🎧 Listen to the full conversation with Michelle Halls on the Dr.
- 📰 GPCR Weekly News, September 18 to 24, 2023
If you couldn't make it, no sweat – our premium members can always go back and watch the recorded talks Short talk selections will be announced soon. Abstract submissions close on October 2nd. All information is available on the Logo Contest page. Program Receives €4 Million Grant Confo Therapeutics Appoints Stephen Dowd As Chief Business Officer Call
- Adhesion GPCR Consortium Newsletter - May 2024
The family of adhesion GPCRs called the Latrophilins or ADGRLs first captured my attention due to their through a suggestion from one of my colleagues to join this select group, which was getting together to talk I still remember entering the Hall at Boston ́s Children Hospital, going to register and being asked Also, seeing the expanding diversity among the aGPCR community, added to the fact that this will all PMID 38421639 Systematic assessment of the tethered agonist-dependent activities of all 33 aGPCRs in
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
Hi GPCR Fanatics, This week’s insights will help you avoid wasted time, poor forecasts, and stalled Let’s get you moving with confidence. 🔍 Quick Wins This Week 🔹 Tell us what matters → News Survey Elevate your strategy → Building clarity in GPCR drug discovery Even the strongest GPCR programs stall—not
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Su , et al. for their fantastic work on Germline mutations in a G protein identify signaling cross-talk Biosciences, INC as a Preferred Supplier at Prendio Crinetics Pharmaceuticals announces executive departure Call research position GPCR Activation and Signaling Germline mutations in a G protein identify signaling cross-talk
- How System-Level GPCR Thinking Prevents Discovery Failures
Weekly research, careers, and industry intelligence; GPCR University; 200+ expert talks; networking; Don’t Fall Behind—Access the Edge You Need Already a Premium Member?
- How GPCR Collaboration Built an Innovation Engine
It was about what we could build together, recalls Michelle Halls. That meant no one could build a fiefdom — and everyone had to talk.
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Thank you to all participants in Dr. Terry Kenakin's educational initiative this fall! We thank all participants for their inspiring contributions and passion. important drug breakthroughs ever Goldman-backed drug developer Septerna raises $288 mln in US IPO Call
- 📰 GPCR Weekly News, August 7 to 13, 2023
Submit your abstracts for poster presentation using this form - short talks will be selected from these GPCR Activation and Signaling Tail engagement of arrestin at the glucagon receptor Gα protein signaling
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
." — DrGPCR University Attendee 🚀 Make better calls with better inputs. . ➤ 🎓 Full GPCR University + 🔬 200+ expert talks 🗞️ Weekly research, careers & event intelligence
- What If the Most Important Part of Your Drug Isn’t What It Binds—But What It Does?
The answer lies in a misunderstood property called efficacy—the power of a drug to trigger a response
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
For others, it’s a calling. The work no longer felt like an assignment—it felt like a calling. Catherine’s story shows that when purpose drives research, science becomes more than a job—it becomes a calling
- Dr. GPCR Summit 2022 is coming!
💡Trainees are invited to participate by presenting a trainee talk, a poster, or a pre-recorded talk
- Understanding Enzyme Inhibition In GPCR Discovery Programs
He argues that early-career researchers often fall into the trap of over-rationalizing too soon—missing Become a Premium Member today. ➤ 🎓 Full GPCR University + 🔬 200+ expert talks 🗞️ Weekly research,
- Biphasic activation of β-arrestin 1 upon interaction with a GPCR revealed by methyl-TROSY NMR
function of G protein-coupled receptors (GPCRs). βarrs typically interact with phosphorylated C-terminal tail (C tail) and transmembrane core (TM core) of GPCRs. However, the effects of the C tail- and TM core-mediated interactions on the conformational activation Here, we show the conformational changes for βarr activation upon the C tail- and TM core-mediated interactions Our NMR analyses demonstrated that while the C tail-mediated interaction alone induces partial activation
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
understand how two mechanisms intersect—and why pharmacologists are critical in addressing this crisis ➤ Call signals today will lead tomorrow’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Dive into our courses, talks, poster presentations, and more! announce that we've been working tirelessly to bring you a simple, beautiful, and insightful collection of all This is your last call before the curtain drops: Classified GPCR News is going VIP-only next year! That's right, all the tidbits below will be for Premium Members ' eyes only.
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
Scientific fads rise and fall.


























